aluates Reports

$ 0.0

Automative

Pneumococcal Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-37E406

Global Pneumococcal Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Pneumococcal Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-37E406

Report

August 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GSK

MSD

Sanofipasteur

CDIBP

Pneumococcal Vaccine- Market Size

The global market for Pneumococcal Vaccine was estimated to be worth US$ 7358 million in 2024 and is forecast to a readjusted size of US$ 7935 million by 2031 with a CAGR of 1.1% during the forecast period 2025-2031.

Pneumococcal Vaccine- Market

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pneumococcal Vaccine by region & country, by Type, and by End User.

The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.

Market Segmentation

Scope of Pneumococcal Vaccine- Market Report

Report Metric	Details
Report Name	Pneumococcal Vaccine- Market
Forecasted market size in 2031	US$ 7935 million
CAGR	1.1%
Forecasted years	2025 - 2031
Segment by Type	PPSV 23 PCV 7/13 PCV 10
Segment by End User	Child Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GSK, MSD, Sanofipasteur, CDIBP
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pneumococcal Vaccine in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Pneumococcal Vaccine- Market size in 2031?

Ans: The Pneumococcal Vaccine- Market size in 2031 will be US$ 7935 million.

What is the Pfizer share in Pneumococcal Vaccine- Market?

Ans: Pfizer is the leader of this industry with 84% market shares.

What is the Pneumococcal Vaccine- Market share by region?

Ans: North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

Who are the main players in the Pneumococcal Vaccine- Market report?

Ans: The main players in the Pneumococcal Vaccine- Market are Pfizer, GSK, MSD, Sanofipasteur, CDIBP

What are the Type segmentation covered in the Pneumococcal Vaccine- Market report?

Ans: The Types covered in the Pneumococcal Vaccine- Market report are PPSV 23, PCV 7/13, PCV 10

What are the End User segmentation covered in the Pneumococcal Vaccine- Market report?

Ans: The End users covered in the Pneumococcal Vaccine- Market report are Child, Adult

1 Market Overview

1.1 Pneumococcal Vaccine Product Introduction

1.2 Global Pneumococcal Vaccine Market Size Forecast

1.2.1 Global Pneumococcal Vaccine Sales Value (2020-2031)

1.2.2 Global Pneumococcal Vaccine Sales Volume (2020-2031)

1.2.3 Global Pneumococcal Vaccine Sales Price (2020-2031)

1.3 Pneumococcal Vaccine Market Trends & Drivers

1.3.1 Pneumococcal Vaccine Industry Trends

1.3.2 Pneumococcal Vaccine Market Drivers & Opportunity

1.3.3 Pneumococcal Vaccine Market Challenges

1.3.4 Pneumococcal Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pneumococcal Vaccine Players Revenue Ranking (2024)

2.2 Global Pneumococcal Vaccine Revenue by Company (2020-2025)

2.3 Global Pneumococcal Vaccine Players Sales Volume Ranking (2024)

2.4 Global Pneumococcal Vaccine Sales Volume by Company Players (2020-2025)

2.5 Global Pneumococcal Vaccine Average Price by Company (2020-2025)

2.6 Key Manufacturers Pneumococcal Vaccine Manufacturing Base and Headquarters

2.7 Key Manufacturers Pneumococcal Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Pneumococcal Vaccine

2.9 Pneumococcal Vaccine Market Competitive Analysis

2.9.1 Pneumococcal Vaccine Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Pneumococcal Vaccine Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 PPSV 23

3.1.2 PCV 7/13

3.1.3 PCV 10

3.2 Global Pneumococcal Vaccine Sales Value by Type

3.2.1 Global Pneumococcal Vaccine Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Pneumococcal Vaccine Sales Value, by Type (2020-2031)

3.2.3 Global Pneumococcal Vaccine Sales Value, by Type (%) (2020-2031)

3.3 Global Pneumococcal Vaccine Sales Volume by Type

3.3.1 Global Pneumococcal Vaccine Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Pneumococcal Vaccine Sales Volume, by Type (2020-2031)

3.3.3 Global Pneumococcal Vaccine Sales Volume, by Type (%) (2020-2031)

3.4 Global Pneumococcal Vaccine Average Price by Type (2020-2031)

4 Segmentation by End User

4.1 Introduction by End User

4.1.1 Child

4.1.2 Adult

4.2 Global Pneumococcal Vaccine Sales Value by End User

4.2.1 Global Pneumococcal Vaccine Sales Value by End User (2020 VS 2024 VS 2031)

4.2.2 Global Pneumococcal Vaccine Sales Value, by End User (2020-2031)

4.2.3 Global Pneumococcal Vaccine Sales Value, by End User (%) (2020-2031)

4.3 Global Pneumococcal Vaccine Sales Volume by End User

4.3.1 Global Pneumococcal Vaccine Sales Volume by End User (2020 VS 2024 VS 2031)

4.3.2 Global Pneumococcal Vaccine Sales Volume, by End User (2020-2031)

4.3.3 Global Pneumococcal Vaccine Sales Volume, by End User (%) (2020-2031)

4.4 Global Pneumococcal Vaccine Average Price by End User (2020-2031)

5 Segmentation by Region

5.1 Global Pneumococcal Vaccine Sales Value by Region

5.1.1 Global Pneumococcal Vaccine Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Pneumococcal Vaccine Sales Value by Region (2020-2025)

5.1.3 Global Pneumococcal Vaccine Sales Value by Region (2026-2031)

5.1.4 Global Pneumococcal Vaccine Sales Value by Region (%), (2020-2031)

5.2 Global Pneumococcal Vaccine Sales Volume by Region

5.2.1 Global Pneumococcal Vaccine Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Pneumococcal Vaccine Sales Volume by Region (2020-2025)

5.2.3 Global Pneumococcal Vaccine Sales Volume by Region (2026-2031)

5.2.4 Global Pneumococcal Vaccine Sales Volume by Region (%), (2020-2031)

5.3 Global Pneumococcal Vaccine Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Pneumococcal Vaccine Sales Value, 2020-2031

5.4.2 North America Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Pneumococcal Vaccine Sales Value, 2020-2031

5.5.2 Europe Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Pneumococcal Vaccine Sales Value, 2020-2031

5.6.2 Asia Pacific Pneumococcal Vaccine Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Pneumococcal Vaccine Sales Value, 2020-2031

5.7.2 South America Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pneumococcal Vaccine Sales Value, 2020-2031

5.8.2 Middle East & Africa Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pneumococcal Vaccine Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Pneumococcal Vaccine Sales Value

6.2.1 Key Countries/Regions Pneumococcal Vaccine Sales Value, 2020-2031

6.2.2 Key Countries/Regions Pneumococcal Vaccine Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Pneumococcal Vaccine Sales Value, 2020-2031

6.3.2 United States Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

6.4 Europe

6.4.1 Europe Pneumococcal Vaccine Sales Value, 2020-2031

6.4.2 Europe Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

6.5 China

6.5.1 China Pneumococcal Vaccine Sales Value, 2020-2031

6.5.2 China Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.5.3 China Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

6.6 Japan

6.6.1 Japan Pneumococcal Vaccine Sales Value, 2020-2031

6.6.2 Japan Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Pneumococcal Vaccine Sales Value, 2020-2031

6.7.2 South Korea Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Pneumococcal Vaccine Sales Value, 2020-2031

6.8.2 Southeast Asia Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

6.9 India

6.9.1 India Pneumococcal Vaccine Sales Value, 2020-2031

6.9.2 India Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

6.9.3 India Pneumococcal Vaccine Sales Value by End User, 2024 VS 2031

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Company Information

7.1.2 Pfizer Introduction and Business Overview

7.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Pfizer Pneumococcal Vaccine Product Offerings

7.1.5 Pfizer Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 GSK Pneumococcal Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 MSD

7.3.1 MSD Company Information

7.3.2 MSD Introduction and Business Overview

7.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 MSD Pneumococcal Vaccine Product Offerings

7.3.5 MSD Recent Development

7.4 Sanofipasteur

7.4.1 Sanofipasteur Company Information

7.4.2 Sanofipasteur Introduction and Business Overview

7.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Sanofipasteur Pneumococcal Vaccine Product Offerings

7.4.5 Sanofipasteur Recent Development

7.5 CDIBP

7.5.1 CDIBP Company Information

7.5.2 CDIBP Introduction and Business Overview

7.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 CDIBP Pneumococcal Vaccine Product Offerings

7.5.5 CDIBP Recent Development

8 Industry Chain Analysis

8.1 Pneumococcal Vaccine Industrial Chain

8.2 Pneumococcal Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pneumococcal Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Pneumococcal Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

GSK

MSD

Sanofipasteur

CDIBP

List of Tables

Table 1. Pneumococcal Vaccine Market Trends

Table 2. Pneumococcal Vaccine Market Drivers & Opportunity

Table 3. Pneumococcal Vaccine Market Challenges

Table 4. Pneumococcal Vaccine Market Restraints

Table 5. Global Pneumococcal Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Pneumococcal Vaccine Revenue Market Share by Company (2020-2025)

Table 7. Global Pneumococcal Vaccine Sales Volume by Company (2020-2025) & (K Doses)

Table 8. Global Pneumococcal Vaccine Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Pneumococcal Vaccine Price by Company (2020-2025) & (USD/Dose)

Table 10. Key Manufacturers Pneumococcal Vaccine Manufacturing Base and Headquarters

Table 11. Key Manufacturers Pneumococcal Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Pneumococcal Vaccine

Table 13. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pneumococcal Vaccine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Pneumococcal Vaccine Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Pneumococcal Vaccine Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2020-2025)

Table 20. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2026-2031)

Table 21. Global Pneumococcal Vaccine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Doses)

Table 22. Global Pneumococcal Vaccine Sales Volume by Type (2020-2025) & (K Doses)

Table 23. Global Pneumococcal Vaccine Sales Volume by Type (2026-2031) & (K Doses)

Table 24. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Pneumococcal Vaccine Price by Type (2020-2025) & (USD/Dose)

Table 27. Global Pneumococcal Vaccine Price by Type (2026-2031) & (USD/Dose)

Table 28. Global Pneumococcal Vaccine Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Pneumococcal Vaccine Sales Value by End User (2020-2025) & (US$ Million)

Table 30. Global Pneumococcal Vaccine Sales Value by End User (2026-2031) & (US$ Million)

Table 31. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2020-2025)

Table 32. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2026-2031)

Table 33. Global Pneumococcal Vaccine Sales Volume by End User: 2020 VS 2024 VS 2031 (K Doses)

Table 34. Global Pneumococcal Vaccine Sales Volume by End User (2020-2025) & (K Doses)

Table 35. Global Pneumococcal Vaccine Sales Volume by End User (2026-2031) & (K Doses)

Table 36. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2020-2025)

Table 37. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2026-2031)

Table 38. Global Pneumococcal Vaccine Price by End User (2020-2025) & (USD/Dose)

Table 39. Global Pneumococcal Vaccine Price by End User (2026-2031) & (USD/Dose)

Table 40. Global Pneumococcal Vaccine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Pneumococcal Vaccine Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Pneumococcal Vaccine Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Pneumococcal Vaccine Sales Value by Region (2020-2025) & (%)

Table 44. Global Pneumococcal Vaccine Sales Value by Region (2026-2031) & (%)

Table 45. Global Pneumococcal Vaccine Sales Volume by Region (K Doses): 2020 VS 2024 VS 2031

Table 46. Global Pneumococcal Vaccine Sales Volume by Region (2020-2025) & (K Doses)

Table 47. Global Pneumococcal Vaccine Sales Volume by Region (2026-2031) & (K Doses)

Table 48. Global Pneumococcal Vaccine Sales Volume by Region (2020-2025) & (%)

Table 49. Global Pneumococcal Vaccine Sales Volume by Region (2026-2031) & (%)

Table 50. Global Pneumococcal Vaccine Average Price by Region (2020-2025) & (USD/Dose)

Table 51. Global Pneumococcal Vaccine Average Price by Region (2026-2031) & (USD/Dose)

Table 52. Key Countries/Regions Pneumococcal Vaccine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Pneumococcal Vaccine Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Pneumococcal Vaccine Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Pneumococcal Vaccine Sales Volume, (2020-2025) & (K Doses)

Table 56. Key Countries/Regions Pneumococcal Vaccine Sales Volume, (2026-2031) & (K Doses)

Table 57. Pfizer Company Information

Table 58. Pfizer Introduction and Business Overview

Table 59. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 60. Pfizer Pneumococcal Vaccine Product Offerings

Table 61. Pfizer Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 65. GSK Pneumococcal Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. MSD Company Information

Table 68. MSD Introduction and Business Overview

Table 69. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 70. MSD Pneumococcal Vaccine Product Offerings

Table 71. MSD Recent Development

Table 72. Sanofipasteur Company Information

Table 73. Sanofipasteur Introduction and Business Overview

Table 74. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 75. Sanofipasteur Pneumococcal Vaccine Product Offerings

Table 76. Sanofipasteur Recent Development

Table 77. CDIBP Company Information

Table 78. CDIBP Introduction and Business Overview

Table 79. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 80. CDIBP Pneumococcal Vaccine Product Offerings

Table 81. CDIBP Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Pneumococcal Vaccine Downstream Customers

Table 85. Pneumococcal Vaccine Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Pneumococcal Vaccine Product Picture

Figure 2. Global Pneumococcal Vaccine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Pneumococcal Vaccine Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Pneumococcal Vaccine Sales Volume (2020-2031) & (K Doses)

Figure 5. Global Pneumococcal Vaccine Sales Price (2020-2031) & (USD/Dose)

Figure 6. Pneumococcal Vaccine Report Years Considered

Figure 7. Global Pneumococcal Vaccine Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Pneumococcal Vaccine Players Sales Volume Ranking (2024) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Vaccine Revenue in 2024

Figure 10. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. PPSV 23 Picture

Figure 12. PCV 7/13 Picture

Figure 13. PCV 10 Picture

Figure 14. Global Pneumococcal Vaccine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Pneumococcal Vaccine Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Pneumococcal Vaccine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Doses)

Figure 17. Global Pneumococcal Vaccine Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Pneumococcal Vaccine Price by Type (2020-2031) & (USD/Dose)

Figure 19. Product Picture of Child

Figure 20. Product Picture of Adult

Figure 21. Global Pneumococcal Vaccine Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Pneumococcal Vaccine Sales Value Market Share by End User, 2024 & 2031

Figure 23. Global Pneumococcal Vaccine Sales Volume by End User (2020 VS 2024 VS 2031) & (K Doses)

Figure 24. Global Pneumococcal Vaccine Sales Volume Market Share by End User, 2024 & 2031

Figure 25. Global Pneumococcal Vaccine Price by End User (2020-2031) & (USD/Dose)

Figure 26. North America Pneumococcal Vaccine Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Pneumococcal Vaccine Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Pneumococcal Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Pneumococcal Vaccine Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Pneumococcal Vaccine Sales Volume (%), (2020-2031)

Figure 38. United States Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 41. Europe Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 44. China Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 46. China Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 47. Japan Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 50. South Korea Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 53. Southeast Asia Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 56. India Pneumococcal Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Pneumococcal Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 58. India Pneumococcal Vaccine Sales Value by End User (%), 2024 VS 2031

Figure 59. Pneumococcal Vaccine Industrial Chain

Figure 60. Pneumococcal Vaccine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025

Global Pneumonia Vaccine Market Insights Forecast to 2030

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacterial Vaccines for Humans Market Research Report 2024

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Testing Market Research Report 2024

Global Meningococcal Infections Vaccine Market Insights Forecast to 2030

Global Pneumonia Therapeutics Market Research Report 2024

Global Vaccines For Children Market Insights Forecast to 2030

Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024

Global Poliomyelitis Vaccine Market Research Report 2025

Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibacterial Vaccines Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions